Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Hedychium spicatum has medicinal properties but needs more research for scientific validation and use.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Taking too many vitamin and mineral supplements can cause serious health problems.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.